These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

595 related articles for article (PubMed ID: 8929414)

  • 1. Discovering high-affinity ligands for proteins: SAR by NMR.
    Shuker SB; Hajduk PJ; Meadows RP; Fesik SW
    Science; 1996 Nov; 274(5292):1531-4. PubMed ID: 8929414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear magnetic resonance methods for studying protein-ligand complexes.
    Petros AM; Fesik SW
    Methods Enzymol; 1994; 239():717-39. PubMed ID: 7530321
    [No Abstract]   [Full Text] [Related]  

  • 3. Antascomicins A, B, C, D and E. Novel FKBP12 binding compounds from a Micromonospora strain.
    Fehr T; Sanglier JJ; Schuler W; Gschwind L; Ponelle M; Schilling W; Wioland C
    J Antibiot (Tokyo); 1996 Mar; 49(3):230-3. PubMed ID: 8626235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An automated method for dynamic ligand design.
    Miranker A; Karplus M
    Proteins; 1995 Dec; 23(4):472-90. PubMed ID: 8749844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic NMR studies of ligand-receptor interactions: design and analysis of a rapidly exchanging complex of FKBP-12/FK506 with a 24 kDa calcineurin fragment.
    Fejzo J; Lepre CA; Peng JW; Su MS; Thomson JA; Moore JM
    Protein Sci; 1996 Sep; 5(9):1917-21. PubMed ID: 8880916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consensus preferred hydration sites in six FKBP12-drug complexes.
    Faerman CH; Karplus PA
    Proteins; 1995 Sep; 23(1):1-11. PubMed ID: 8539241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure comparison of native and mutant human recombinant FKBP12 complexes with the immunosuppressant drug FK506 (tacrolimus).
    Itoh S; Navia MA
    Protein Sci; 1995 Nov; 4(11):2261-8. PubMed ID: 8563622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-function relationships in the FK506-binding protein (FKBP) family of peptidylprolyl cis-trans isomerases.
    Kay JE
    Biochem J; 1996 Mar; 314 ( Pt 2)(Pt 2):361-85. PubMed ID: 8670043
    [No Abstract]   [Full Text] [Related]  

  • 9. Three-dimensional structure of the FK506 binding protein/ascomycin complex in solution by heteronuclear three- and four-dimensional NMR.
    Meadows RP; Nettesheim DG; Xu RX; Olejniczak ET; Petros AM; Holzman TF; Severin J; Gubbins E; Smith H; Fesik SW
    Biochemistry; 1993 Jan; 32(3):754-65. PubMed ID: 7678499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 15N NMR relaxation studies of the FK506 binding protein: dynamic effects of ligand binding and implications for calcineurin recognition.
    Cheng JW; Lepre CA; Moore JM
    Biochemistry; 1994 Apr; 33(14):4093-100. PubMed ID: 7512379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunophilins, ligands, and the control of signal transduction.
    Schreiber SL; Crabtree GR
    Harvey Lect; 1995-1996; 91():99-114. PubMed ID: 9127988
    [No Abstract]   [Full Text] [Related]  

  • 12. Crystal structures of human calcineurin and the human FKBP12-FK506-calcineurin complex.
    Kissinger CR; Parge HE; Knighton DR; Lewis CT; Pelletier LA; Tempczyk A; Kalish VJ; Tucker KD; Showalter RE; Moomaw EW
    Nature; 1995 Dec; 378(6557):641-4. PubMed ID: 8524402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-based drug design ten years on.
    Robertus J
    Nat Struct Biol; 1994 Jun; 1(6):352-4. PubMed ID: 7545074
    [No Abstract]   [Full Text] [Related]  

  • 14. The automatic search for ligand binding sites in proteins of known three-dimensional structure using only geometric criteria.
    Peters KP; Fauck J; Frömmel C
    J Mol Biol; 1996 Feb; 256(1):201-13. PubMed ID: 8609611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NMR structure-based drug design.
    Fesik SW
    J Biomol NMR; 1993 May; 3(3):261-9. PubMed ID: 7689377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of PMF scoring in docking weak ligands to the FK506 binding protein.
    Muegge I; Martin YC; Hajduk PJ; Fesik SW
    J Med Chem; 1999 Jul; 42(14):2498-503. PubMed ID: 10411471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Template-based docking of a prolactin receptor proline-rich motif octapeptide to FKBP12: implications for cytokine receptor signaling.
    Soman KV; Hanks BA; Tien H; Chari MV; O'Neal KD; Morrisett JD
    Protein Sci; 1997 May; 6(5):999-1008. PubMed ID: 9144770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solution structure of FK506 bound to the R42K, H87V double mutant of FKBP-12.
    Lepre CA; Pearlman DA; Cheng JW; DeCenzo MT; Livingston DJ; Moore JM
    Biochemistry; 1994 Nov; 33(46):13571-80. PubMed ID: 7524662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FK506 and the role of immunophilins in nerve regeneration.
    Gold BG
    Mol Neurobiol; 1997 Dec; 15(3):285-306. PubMed ID: 9457703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 15N NMR relaxation studies of the FK506 binding protein: backbone dynamics of the uncomplexed receptor.
    Cheng JW; Lepre CA; Chambers SP; Fulghum JR; Thomson JA; Moore JM
    Biochemistry; 1993 Sep; 32(35):9000-10. PubMed ID: 7690248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.